TABLE 1.

RvD1 and RvD2 significantly increase glycoconjugate secretion

Agonist	Glycoconjugate secretion
Basal	1.0 ± 0.0
Cch 10−4 M	1.9 ± 0.3a
VIP 10−8 M	1.3 ± 0.1a
RvD1 10−8 M	1.8 ± 0.1a
RvD2 10−8 M	2.5 ± 0.4a

Data are means ± sem from 3 independent experiments. ^aIndicates significant difference from basal.